Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy – Part 1

[1]  G F Cahill,et al.  Brain metabolism during fasting. , 1967, The Journal of clinical investigation.

[2]  R. Naquet,et al.  Effects of opiate-like peptides, morphine, and naloxone in the photosensitive baboon, papio papio , 1979, Brain Research.

[3]  R. Nicoll,et al.  Epileptiform burst afterhyperolarization: calcium-dependent potassium potential in hippocampal CA1 pyramidal cells. , 1980, Science.

[4]  L. Sokoloff,et al.  Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. , 1981, Federation proceedings.

[5]  R K Wong,et al.  Cellular factors influencing GABA response in hippocampal pyramidal cells. , 1982, Journal of neurophysiology.

[6]  B. Connors,et al.  Electrophysiological properties of neocortical neurons in vitro. , 1982, Journal of neurophysiology.

[7]  B. Connors.  Initiation of synchronized neuronal bursting in neocortex , 1984, Nature.

[8]  J. Noebels,et al.  A single gene error of noradrenergic axon growth synchronizes central neurones , 1984, Nature.

[9]  W. Löscher,et al.  Evidence for impaired GABAergic activity in the substantia nigra of amygdaloid kindled rats , 1985, Brain Research.

[10]  R. Macdonald,et al.  Anticonvulsant drug mechanisms of action. , 1985, Federation proceedings.

[11]  W. Löscher,et al.  Low Levels of γ‐Aminobutyric Acid in Cerebrospinal Fluid of Dogs with Epilepsy , 1986 .

[12]  P. Schwartzkroin,et al.  Spontaneous Rhythmic Synchronous Activity in Epileptic Human and Normal Monkey Temporal Lobe , 1986, Epilepsia.

[13]  F. Andermann,et al.  Progressive myoclonus epilepsies: specific causes and diagnosis. , 1986, The New England journal of medicine.

[14]  W. Löscher,et al.  Low levels of gamma-aminobutyric acid in cerebrospinal fluid of dogs with epilepsy. , 1986, Journal of neurochemistry.

[15]  Y. Mayanagi,et al.  Decreased dopamine level in the epileptic focus. , 1987, Research communications in chemical pathology and pharmacology.

[16]  Oxcarbazepine , 1989, The Lancet.

[17]  D. McCormick,et al.  GABA as an inhibitory neurotransmitter in human cerebral cortex. , 1989, Journal of neurophysiology.

[18]  D. Prince,et al.  Specific petit mal anticonvulsants reduce calcium currents in thalamic neurons , 1989, Neuroscience Letters.

[19]  D. Prince,et al.  Characterization of ethosuximide reduction of low‐threshold calcium current in thalamic neurons , 1989, Annals of neurology.

[20]  J. McNamara,et al.  Excitatory amino acid receptors in epilepsy. , 1990, Trends in pharmacological sciences.

[21]  J. Ebersole.  Electrophysiologic Methods of Evaluating Epilepsy , 1990, Seminars in neurology.

[22]  P. D. De Deyn,et al.  Epilepsy and the GABA-hypothesis a brief review and some examples. , 1990, Acta neurologica Belgica.

[23]  Alan A. Wilson,et al.  Quantification of mu and non–mu opiate receptors in temporal lobe epilepsy using positron emission tomography , 1991, Annals of neurology.

[24]  J. Sikela,et al.  A novel gamma subunit of the GABAA receptor identified using the polymerase chain reaction. , 1991, FEBS letters.

[25]  J. Sikela,et al.  A novel γ subunit of the GABAA receptor identified using the polymerase chain reaction , 1991 .

[26]  Margaret Robertson,et al.  Identification of a mutation in the gene causing hyperkalemic periodic paralysis , 1991, Cell.

[27]  E J Speckmann,et al.  The neurophysiological basis of epileptic activity: a condensed overview. , 1991, Epilepsy research. Supplement.

[28]  Speckmann Ej,et al.  The neurophysiological basis of epileptic activity: a condensed overview. , 1991 .

[29]  M. Avoli,et al.  Excitatory synaptic transmission mediated by NMDA and non-NMDA receptors in the superficial/middle layers of the epileptogenic human neocortex maintained in vitro , 1992, Neuroscience Letters.

[30]  T. Jentsch,et al.  Regions involved in the opening of CIC-2 chloride channel by voltage and cell volume , 1992, Nature.

[31]  M. Schmutz,et al.  GABAB receptors in various in vitro and in vivo models of epilepsy: A study with the GABAB receptor blocker CGP 35348 , 1992, Neuroscience.

[32]  T. Serikawa,et al.  Decreased Dopamine and Increased Norepinephrine Levels in the Spontaneously Epileptic Rat, a Double Mutant Rat , 1993, Epilepsia.

[33]  R. Traub,et al.  Are there unifying principles underlying the generation of epileptic afterdischarges in vitro? , 1994, Progress in brain research.

[34]  D. Schmidt.  Clobazam for Treatment of Intractable Epilepsy: A Critical Assessment , 1994, Epilepsia.

[35]  B. Bourgeois.  Felbamate in the Treatment of Partial‐Onset Seizures , 1994, Epilepsia.

[36]  M. Kasuga,et al.  Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. , 1994, The Biochemical journal.

[37]  C. Remy.  Clobazam in the Treatment of Epilepsy: A Review of the Literature , 1994, Epilepsia.

[38]  J. McNamara,et al.  Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. , 1994, Science.

[39]  C. Marsden,et al.  Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder , 1994, The Lancet.

[40]  C. B. Davis,et al.  Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant , 1994, Epilepsia.

[41]  J G Jefferys,et al.  Experimental neurobiology of epilepsies. , 1994, Current opinion in neurology.

[42]  JO McNamara,et al.  Cellular and molecular basis of epilepsy , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  M. Scanziani,et al.  Role of excitatory amino acid and GABAB receptors in the generation of epileptiform activity in disinhibited hippocampal slice cultures , 1994, Neuroscience.

[44]  B. Meldrum.  The role of glutamate in epilepsy and other CNS disorders , 1994, Neurology.

[45]  P. Carlen,et al.  Modulation of gap junctional mechanisms during calcium-free induced field burst activity: a possible role for electrotonic coupling in epileptogenesis , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  W. Catterall,et al.  Role of calcium channel subtypes in calcium transients in hippocampal CA3 neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  A. Coenen,et al.  Role of L‐Type Calcium Channel Modulation in Nonconvulsive Epilepsy in Rats , 1995, Epilepsia.

[48]  A. Coenen,et al.  Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats , 1995, Neuroscience Letters.

[49]  U. Misgeld,et al.  A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system , 1995, Progress in Neurobiology.

[50]  K. Staley,et al.  Differential expression of an inwardly rectifying chloride conductance in rat brain neurons: a potential mechanism for cell-specific modulation of postsynaptic inhibition , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[51]  C. Marsden,et al.  Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. , 1995, Brain : a journal of neurology.

[52]  O. Snead,et al.  Basic mechanisms of generalized absence seizures , 1995, Annals of neurology.

[53]  J. Aicardi,et al.  Vigabatrin as Initial Therapy for Infantile Spasms: A European Retrospective Survey , 1996, Epilepsia.

[54]  P. Mangan,et al.  Profound disturbances of pre- and postsynaptic GABAB-receptor-mediated processes in region CA1 in a chronic model of temporal lobe epilepsy. , 1996, Journal of neurophysiology.

[55]  B. Meldrum.  Update on the Mechanism of Action of Antiepileptic Drugs , 1996, Epilepsia.

[56]  M. Johnston.  Developmental Aspects of Epileptogenesis , 1996, Epilepsia.

[57]  C. Wilcox,et al.  Alteration of GABAA Receptor Function Following Gene Transfer of the CLC-2 Chloride Channel , 1996, Neuron.

[58]  Richard Hawkes,et al.  Absence Epilepsy in Tottering Mutant Mice Is Associated with Calcium Channel Defects , 1996, Cell.

[59]  Y. Jan,et al.  Voltage‐gated and inwardly rectifying potassium channels , 1997, The Journal of physiology.

[60]  D. Hanahan,et al.  Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Coumel,et al.  A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome , 1997, Nature Genetics.

[62]  M. Vergnes,et al.  Opposite effects of GABAB receptor antagonists on absences and convulsive seizures. , 1997, European journal of pharmacology.

[63]  T. Jentsch,et al.  Chloride channels: An emerging molecular picture , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[64]  W Zieglgänsberger,et al.  Presynaptic and postsynaptic GABAB receptors of neocortical neurons of the rat in vitro: Differences in pharmacology and ionic mechanisms , 1997, Synapse.

[65]  I. Scheffer,et al.  Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. , 1997, Brain : a journal of neurology.

[66]  B. Gähwiler,et al.  Either N- or P-type Calcium Channels Mediate GABA Release at Distinct Hippocampal Inhibitory Synapses , 1997, Neuron.

[67]  S. Jordt,et al.  Molecular dissection of gating in the ClC‐2 chloride channel , 1997, The EMBO journal.

[68]  M. Privitera.  Topiramate: A New Antiepileptic Drug , 1997, The Annals of pharmacotherapy.

[69]  R. Ophoff,et al.  P/Q-type Ca2+ channel defects in migraine, ataxia and epilepsy. , 1998, Trends in pharmacological sciences.

[70]  Samuel F. Berkovic,et al.  Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel ß1 subunit gene SCN1B , 1998, Nature Genetics.

[71]  M. Schuelke,et al.  Epilepsia partialis continua associated with a homoplasmic mitochondrial tRNASer(UCN) mutation , 1998, Annals of neurology.

[72]  E. Ben-Menachem,et al.  Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients , 1998, Epilepsy Research.

[73]  P. Halász,et al.  The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy , 1998, Brain Research.

[74]  B. Gähwiler,et al.  L-Type Ca2+ channels mediate the slow Ca2+-dependent afterhyperpolarization current in rat CA3 pyramidal cells in vitro. , 1998, Journal of neurophysiology.

[75]  Douglas C. Wallace,et al.  Radicals r'aging , 1998, Nature Genetics.

[76]  C. Marsden,et al.  Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. , 1998, American journal of human genetics.

[77]  D. Pongratz,et al.  Progressive myoclonus epilepsy and mitochondrial myopathy associated with mutations in the tRNAser(UCN) gene , 1998, Annals of neurology.

[78]  D. Bertrand,et al.  Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy , 1998, British journal of pharmacology.

[79]  M. Schuelke,et al.  Epilepsia partialis continua associated with a homoplasmic mitochondrial tRNA(Ser(UCN)) mutation. , 1998, Annals of neurology.

[80]  S Clark,et al.  Mechanisms of epileptogenesis. , 1999, Advances in neurology.

[81]  R. Deisz.  The GABAB receptor antagonist CGP 55845A reduces presynaptic GABAB actions in neocortical neurons of the rat in vitro , 1999, Neuroscience.

[82]  L. Ellerby,et al.  Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[83]  J. McNamara.  Emerging insights into the genesis of epilepsy , 1999, Nature.

[84]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[85]  J. Rho,et al.  The Pharmacologic Basis of Antiepileptic Drug Action , 1999, Epilepsia.

[86]  R. Naviaux,et al.  Mitochondrial DNA polymerase γ deficiency and mtDNA depletion in a child with Alpers' syndrome , 1999 .

[87]  R. Köhling,et al.  Contribution of L-type calcium channels to epileptiform activity in hippocampal and neocortical slices of guinea-pigs , 1999, Neuroscience.

[88]  R. Naviaux,et al.  Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. , 1999, Annals of neurology.

[89]  S. Dimauro,et al.  Mitochondrial genes for generalized epilepsies. , 1999, Advances in neurology.

[90]  M. Vreugdenhil,et al.  Modulation of Sodium Currents in Rat CA1 Neurons by Carbamazepine and Valproate After Kindling Epileptogenesis , 1999, Epilepsia.

[91]  R. Fisher,et al.  Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop? , 1999, Neurology.

[92]  M. Krug,et al.  Effects of nicardipine, an antagonist of l-type voltage-dependent calcium channels, on kindling development, kindling-induced learning deficits and hippocampal potentiation phenomena , 1999, Neuropharmacology.

[93]  S. Sombati,et al.  Cellular Actions of Topiramate: Blockade of Kainate‐Evoked Inward Currents in Cultured Hippocampal Neurons , 2000, Epilepsia.

[94]  W. Catterall,et al.  From Ionic Currents to Molecular Mechanisms The Structure and Function of Voltage-Gated Sodium Channels , 2000, Neuron.

[95]  T. Mori,et al.  Carbon-monoxide poisoning presenting as an afebrile seizure. , 2000, Pediatric neurology.

[96]  W. Catterall.  Structure and regulation of voltage-gated Ca2+ channels. , 2000, Annual review of cell and developmental biology.

[97]  R. D'Hooge,et al.  Pathophysiology of epilepsy. , 2000, Acta neurologica Belgica.

[98]  A. Marson,et al.  Zonisamide for drug-resistant partial epilepsy. , 2000, The Cochrane database of systematic reviews.

[99]  Christopher Miller.  An overview of the potassium channel family , 2000, Genome Biology.

[100]  M. Berger,et al.  Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[101]  C. Dravet.  Severe Myoclonic Epilepsy in Infants and its Related Syndromes , 1999, Epilepsia.

[102]  D. Gilbert,et al.  The Ketogenic Diet: Seizure Control Correlates Better With Serum β-Hydroxybutyrate Than With Urine Ketones , 2000, Journal of child neurology.

[103]  N. Nishiyama,et al.  L-type Ca2+ channel blocker inhibits mossy fiber sprouting and cognitive deficits following pilocarpine seizures in immature mice , 2000, Neuroscience.

[104]  F. Ashcroft.  The Yin and Yang of the K(ATP) channel. , 2000, The Journal of physiology.

[105]  S. Gultekin,et al.  Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. , 2000, Brain : a journal of neurology.

[106]  A. Brooks-Kayal,et al.  Role of excitatory amino acids in developmental epilepsies. , 2001, Mental Retardation and Developmental Disabilities Research Reviews.

[107]  H. Lerche,et al.  Ion channels and epilepsy. , 2001, American journal of medical genetics.

[108]  J. Stephenson.  Anoxic seizures: self-terminating syncopes. , 2001, Epileptic disorders : international epilepsy journal with videotape.

[109]  John Gordon Ralph Jefferys,et al.  Ca2+ entry through l-type Ca2+ channels helps terminate epileptiform activity by activation of a Ca2+ dependent afterhyperpolarisation in hippocampal CA3. , 2001, Neuroscience.

[110]  D. Bertrand,et al.  Neuronal nicotinic receptors: from protein structure to function , 2001, FEBS letters.

[111]  E. Faught,et al.  Pharmacokinetic Considerations in Prescribing Antiepileptic Drugs , 2001, Epilepsia.

[112]  D. McCormick,et al.  On the cellular and network bases of epileptic seizures. , 2001, Annual review of physiology.

[113]  D. Lowenstein,et al.  Hippocampal Heterotopia Lack Functional Kv4.2 Potassium Channels in the Methylazoxymethanol Model of Cortical Malformations and Epilepsy , 2001, The Journal of Neuroscience.

[114]  J. Dichgans,et al.  GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen’s encephalitis , 2001, Neurology.

[115]  Michel Baulac,et al.  First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene , 2001, Nature Genetics.

[116]  A. George,et al.  Molecular Basis of an Inherited Epilepsy , 2002, Neuron.

[117]  I. Scheffer,et al.  Sodium-channel defects in benign familial neonatal-infantile seizures , 2002, The Lancet.

[118]  Wei-Yang Lu,et al.  Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy , 2002, Nature Genetics.

[119]  R. Köhling.  Neuroscience. GABA becomes exciting. , 2002, Science.

[120]  T. Voit,et al.  Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain – a review , 2002, European Journal of Pediatrics.

[121]  T. Baram,et al.  Developmental Febrile Seizures Modulate Hippocampal Gene Expression of Hyperpolarization-Activated Channels in an Isoform- and Cell-Specific Manner , 2002, The Journal of Neuroscience.

[122]  R. Spreafico,et al.  Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures , 2002, Journal of Neuroimmunology.

[123]  Steven Petrou,et al.  Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. , 2002, American journal of human genetics.

[124]  D. Bertrand,et al.  Nicotinic receptors in circuit excitability and epilepsy. , 2002, Journal of neurobiology.

[125]  W. Kunz.  The role of mitochondria in epileptogenesis , 2002, Current opinion in neurology.

[126]  Rüdiger Köhling,et al.  GABA Becomes Exciting , 2002, Science.

[127]  R. Deisz.  Cellular mechanisms of pharmacoresistance in slices from epilepsy surgery. , 2002, Novartis Foundation symposium.

[128]  W. Hauser,et al.  Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features , 2002, Nature Genetics.

[129]  H. Lester,et al.  Five ADNFLE Mutations Reduce the Ca2+ Dependence of the Mammalian α4β2 Acetylcholine Response , 2003 .

[130]  H. Lester,et al.  Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian alpha4beta2 acetylcholine response. , 2003, The Journal of physiology.

[131]  S. Horvath,et al.  Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies , 2003, Nature Genetics.

[132]  H. Beck,et al.  Enhanced Expression of a Specific Hyperpolarization-Activated Cyclic Nucleotide-Gated Cation Channel (HCN) in Surviving Dentate Gyrus Granule Cells of Human and Experimental Epileptic Hippocampus , 2003, The Journal of Neuroscience.

[133]  O. Devinsky,et al.  Epilepsy-Associated Dysfunction in the Voltage-Gated Neuronal Sodium Channel SCN1A , 2003, The Journal of Neuroscience.

[134]  T. Freund,et al.  Loss of interneurons innervating pyramidal cell dendrites and axon initial segments in the CA1 region of the hippocampus following pilocarpine‐induced seizures , 2003, The Journal of comparative neurology.

[135]  I. Scheffer,et al.  Phenotypic Comparison of Two Scottish Families with Mutations in Different Genes Causing Autosomal Dominant Nocturnal Frontal Lobe Epilepsy , 2003, Epilepsia.

[136]  Zhijian Yao,et al.  Association between genetic variation of CACNA1H and childhood absence epilepsy , 2003, Annals of neurology.

[137]  D. Bertrand,et al.  A New Chrna4 Mutation with Low Penetrance in Nocturnal Frontal Lobe Epilepsy , 2003, Epilepsia.

[138]  Simon Shorvon,et al.  Treatment of Epilepsy , 2004 .

[139]  B. Boeve,et al.  Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody , 2004, Neurology.

[140]  K. Metrakos,et al.  Plasma amino acids in 3/sec spike-wave epilepsy , 1980, Neurochemical Research.

[141]  M. Rossor,et al.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. , 2004, Brain : a journal of neurology.

[142]  D. Johnston,et al.  Seizure-Induced Plasticity of h Channels in Entorhinal Cortical Layer III Pyramidal Neurons , 2004, Neuron.

[143]  D. Johnston,et al.  Acquired Dendritic Channelopathy in Temporal Lobe Epilepsy , 2004, Science.

[144]  C. Woods,et al.  Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders , 2004, BMC neurology.

[145]  R. Vannucci,et al.  Glucose transport in developing rat brain: Glucose transporter proteins, rate constants and cerebral glucose utilization , 1994, Molecular and Cellular Biochemistry.

[146]  Ying-Hui Fu,et al.  Channels and disease: past, present, and future. , 2004, Archives of neurology.

[147]  I. Scheffer,et al.  Benign familial neonatal‐infantile seizures: Characterization of a new sodium channelopathy , 2004, Annals of neurology.

[148]  Luigi Ferini-Strambi,et al.  Autosomal dominant nocturnal frontal lobe epilepsy , 2004, Journal of Neurology.

[149]  M. Cunnington.  The International Lamotrigine Pregnancy Registry Update for the Epilepsy Foundation , 2004, Epilepsia.

[150]  S. Moshé,et al.  Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. , 2005, American journal of human genetics.

[151]  C. Elger,et al.  Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. , 2005, Brain : a journal of neurology.

[152]  T. Freund,et al.  Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus. , 2004, Brain : a journal of neurology.

[153]  A. Vincent,et al.  Autoimmune channelopathies , 2005, Nature Clinical Practice Neurology.

[154]  R. Olsen,et al.  GABAA Receptor-Associated Protein Regulates GABAA Receptor Cell-Surface Number in Xenopus laevis Oocytes , 2005, Molecular Pharmacology.

[155]  Mark Gardiner,et al.  Genetics of Idiopathic Generalized Epilepsies , 2005, Epilepsia.

[156]  J. Kantrowitz,et al.  Synaptic depolarizing GABA Response in adults is excitatory and proconvulsive when GABAB receptors are blocked. , 2005, Journal of neurophysiology.

[157]  P. Murphy.  Use of the ketogenic diet as a treatment for epilepsy refractory to drug treatment , 2005, Expert review of neurotherapeutics.

[158]  T. Baram,et al.  Formation of heteromeric hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the hippocampus is regulated by developmental seizures , 2005, Neurobiology of Disease.

[159]  G. Lu,et al.  Protein Kinase C-Independent Effects of Protein Kinase D3 in Glucose Transport in L6 Myotubes , 2005, Molecular Pharmacology.

[160]  E. Kobayashi,et al.  Familial Temporal Lobe Epilepsy with Auditory Features , 2005, Epilepsia.

[161]  D. Binder,et al.  Functional changes in astroglial cells in epilepsy , 2006, Glia.

[162]  B. Fakler,et al.  The Epilepsy-Linked Lgi1 Protein Assembles into Presynaptic Kv1 Channels and Inhibits Inactivation by Kvβ1 , 2006, Neuron.

[163]  Samuel F. Berkovic,et al.  Human epilepsies: interaction of genetic and acquired factors , 2006, Trends in Neurosciences.

[164]  M. Avoli,et al.  Synaptic hyperexcitability of deep layer neocortical cells in a genetic model of absence seizures , 2005, Genes, brain, and behavior.

[165]  M. Leppert,et al.  Andreas Rett and benign familial neonatal convulsions revisited , 2006, Neurology.

[166]  I. Scheffer,et al.  Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants , 2007, Annals of neurology.

[167]  E. Kossoff,et al.  The Ketogenic Diet: One Decade Later , 2007, Pediatrics.

[168]  V. Napolioni,et al.  Genetic polymorphisms and idiopathic generalized epilepsies. , 2007, Pediatric neurology.

[169]  M. Seeck,et al.  Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies , 2009, BMJ Case Reports.

[170]  Barbara C. Jobst,et al.  Handbook of Epilepsy Treatment By Simon Shorvon 2010 Wiley–Blackwell , 2011, Epilepsy & Behavior.